Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurexan for Short-Term Insomnia and Stress
NCT06278077Phase 2Completed
- Sponsor
- Heel
- Start
- Sep 2023
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Neurexan in Insomnia, acute stress reaction (ASR), sponsored by Heel. Started Sep 2023; status: completed.
02
Drugs
Neurexan
03
Conditions
Insomniaacute stress reaction (ASR)
Beyond the preview
Go deeper on NCT06278077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06278077.